The Acute Bacterial Skin And Skin Structure Infections Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Infection Type (Hospital-acquired ABSSI, Community-acquired ABSSI), By Route of Administration (Oral, Parenteral, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies).
The Acute Bacterial Skin and Skin Structure Infections Market in 2024 respond to the challenges posed by bacterial infections, offering advanced therapeutic solutions for skin and soft tissue infections. Characterized by the prevalence of resistant bacterial strains, this market showcases novel antibiotics and treatment modalities that address the complexity of acute bacterial skin and skin structure infections. With a focus on efficacy, safety, and reducing the burden of antibiotic resistance, the market plays a vital role in ensuring timely and effective interventions for patients grappling with these challenging infections.
A prominent trend in the Acute Bacterial Skin and Skin Structure Infections (ABSSSI) market is the escalating prevalence of antibiotic-resistant infections. The increasing resistance of bacteria to conventional antibiotics is driving the demand for advanced and targeted therapeutic solutions. This trend highlights the urgency for innovative treatments to address the challenges posed by resistant bacterial strains in ABSSSI cases, pushing the market towards the development of novel antibacterial agents.
The primary driver propelling the ABSSSI market is the growing incidence of skin infections and soft tissue complications, contributing to a substantial disease burden globally. Factors such as an aging population, rising cases of diabetes, and an increase in invasive medical procedures contribute to the higher susceptibility of individuals to skin infections. This surge in ABSSSI cases necessitates effective treatments, fostering the development of new therapies and driving the overall growth of the market.
A potential opportunity in the ABSSSI market lies in the development of broad-spectrum antibiotics and combination therapies. As the complexity of bacterial infections increases, there is a need for treatments that can target a wide range of pathogens and address potential resistance issues. Companies investing in the research and development of broad-spectrum antibiotics and combination therapies have the opportunity to provide comprehensive solutions, catering to the diverse microbial landscape associated with ABSSSI. This approach could lead to more efficacious and versatile treatment options, addressing the evolving challenges in the management of bacterial skin infections.
By Infection Type
By Route of Administration
By Distribution Channel
Geographical Analysis
*list not exhaustive
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Acute Bacterial Skin And Skin Structure Infections Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Acute Bacterial Skin And Skin Structure Infections Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Acute Bacterial Skin And Skin Structure Infections Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Acute Bacterial Skin And Skin Structure Infections Market Size Outlook, $ Million, 2021 to 2030
3.2 Acute Bacterial Skin And Skin Structure Infections Market Outlook by Type, $ Million, 2021 to 2030
3.3 Acute Bacterial Skin And Skin Structure Infections Market Outlook by Product, $ Million, 2021 to 2030
3.4 Acute Bacterial Skin And Skin Structure Infections Market Outlook by Application, $ Million, 2021 to 2030
3.5 Acute Bacterial Skin And Skin Structure Infections Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Acute Bacterial Skin And Skin Structure Infections Market Industry
4.2 Key Market Trends in Acute Bacterial Skin And Skin Structure Infections Market Industry
4.3 Potential Opportunities in Acute Bacterial Skin And Skin Structure Infections Market Industry
4.4 Key Challenges in Acute Bacterial Skin And Skin Structure Infections Market Industry
5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Acute Bacterial Skin And Skin Structure Infections Market Share by Company
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Acute Bacterial Skin And Skin Structure Infections Market Outlook By Segments
7.1 Acute Bacterial Skin And Skin Structure Infections Market Outlook by Segments
By Infection Type
Hospital-acquired ABSSI
Community-acquired ABSSI
By Route of Administration
Oral
Parenteral
Topical
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
8 North America Acute Bacterial Skin And Skin Structure Infections Market Analysis And Outlook To 2030
8.1 Introduction to North America Acute Bacterial Skin And Skin Structure Infections Markets in 2024
8.2 North America Acute Bacterial Skin And Skin Structure Infections Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Acute Bacterial Skin And Skin Structure Infections Market size Outlook by Segments, 2021-2030
By Infection Type
Hospital-acquired ABSSI
Community-acquired ABSSI
By Route of Administration
Oral
Parenteral
Topical
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
9 Europe Acute Bacterial Skin And Skin Structure Infections Market Analysis And Outlook To 2030
9.1 Introduction to Europe Acute Bacterial Skin And Skin Structure Infections Markets in 2024
9.2 Europe Acute Bacterial Skin And Skin Structure Infections Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Acute Bacterial Skin And Skin Structure Infections Market Size Outlook By Segments, 2021-2030
By Infection Type
Hospital-acquired ABSSI
Community-acquired ABSSI
By Route of Administration
Oral
Parenteral
Topical
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
10 Asia Pacific Acute Bacterial Skin And Skin Structure Infections Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific Acute Bacterial Skin And Skin Structure Infections Markets in 2024
10.2 Asia Pacific Acute Bacterial Skin And Skin Structure Infections Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Acute Bacterial Skin And Skin Structure Infections Market size Outlook by Segments, 2021-2030
By Infection Type
Hospital-acquired ABSSI
Community-acquired ABSSI
By Route of Administration
Oral
Parenteral
Topical
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
11 South America Acute Bacterial Skin And Skin Structure Infections Market Analysis And Outlook To 2030
11.1 Introduction to South America Acute Bacterial Skin And Skin Structure Infections Markets in 2024
11.2 South America Acute Bacterial Skin And Skin Structure Infections Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Acute Bacterial Skin And Skin Structure Infections Market size Outlook by Segments, 2021-2030
By Infection Type
Hospital-acquired ABSSI
Community-acquired ABSSI
By Route of Administration
Oral
Parenteral
Topical
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
12 Middle East And Africa Acute Bacterial Skin And Skin Structure Infections Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa Acute Bacterial Skin And Skin Structure Infections Markets in 2024
12.2 Middle East and Africa Acute Bacterial Skin And Skin Structure Infections Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Acute Bacterial Skin And Skin Structure Infections Market size Outlook by Segments, 2021-2030
By Infection Type
Hospital-acquired ABSSI
Community-acquired ABSSI
By Route of Administration
Oral
Parenteral
Topical
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Paratek Pharmaceuticals Inc
Melinta Therapeutics Inc
Allergan PLC
Merck & Co. Inc
Endo Pharmaceuticals Inc
Nabriva Therapeutics PLC
Basilea Pharmaceutica Ltd
Cipher Pharmaceuticals
Menarini Group
Sandoz Inc
Glenmark Pharmaceuticals Ltd
Pfizer Inc
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Infection Type
By Route of Administration
By Distribution Channel
Geographical Analysis
The global Acute Bacterial Skin And Skin Structure Infections Market is one of the lucrative growth markets, poised to register a 8.1% growth (CAGR) between 2024 and 2032.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Paratek Pharmaceuticals Inc, Melinta Therapeutics Inc, Allergan PLC, Merck & Co. Inc, Endo Pharmaceuticals Inc, Nabriva Therapeutics PLC, Basilea Pharmaceutica Ltd, Cipher Pharmaceuticals, Menarini Group, Sandoz Inc, Glenmark Pharmaceuticals Ltd, Pfizer Inc
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume